ONTRUZANT is a prescription medicine approved for the treatment of HER2+ breast cancer. It can be used in combination with certain chemotherapy drugs or alone after treatment with …

ONTRUZANT is a targeted therapy designed to interrupt tumor cell growth in HER2+ breast cancer; ONTRUZANT may stop the HER2 receptors from signaling cancer cells to grow; …

2024年3月26日 · What is Ontruzant? Ontruzant is used to treat certain types of breast cancer or stomach cancer, sometimes in combination with other cancer medicines. Ontruzant is …

Ontruzant is a cancer medicine used to treat the following conditions: early breast cancer (when the cancer has spread within the breast or to the glands under the arm but not to other parts of …

ONTRUZANT is indicated for adjuvant treatment of HER2-overexpressing node-positive or node-negative (ER/PR-negative or with one high-risk feature) breast cancer: Select patients for …

2020年4月15日 · ONTRUZANT is indicated for adjuvant treatment of HER2 overexpressing node positive or node negative (ER/PR negative or with one high risk feature) breast cancer as part …

2025年3月11日 · Ontruzant (trastuzumab-dttb) for injection is a sterile, white to pale yellow, preservative-free lyophilized powder with a cake-like appearance, for intravenous administration.

Ontruzant是重磅乳腺癌疗法赫赛汀（Herceptin）的生物类似药（biosimilar），被批准用于治疗赫赛汀标签中的所有适应症，包括HER2阳性的早期乳腺癌，HER2阳性的转移性乳腺癌， …

Ontruzant is a HER2/neu receptor antagonist indicated for: The treatment of HER2-overexpressing breast cancer. (1.1, 1.2) The treatment of HER2-overexpressing metastatic …

ONTRUZANT is an FDA-approved biosimilar of the drug Herceptin (trastuzumab). How can ONTRUZANT help me? ONTRUZANT is thought to target tumor cell growth in HER2+ breast …